ClinicalTrials.Veeva

Menu

Tobacco Cessation for Sexual Minorities

University of Pittsburgh logo

University of Pittsburgh

Status

Terminated

Conditions

Smoking Cessation

Treatments

Other: Kwit smartphone app

Study type

Interventional

Funder types

Other

Identifiers

NCT03643679
PRO18050656

Details and patient eligibility

About

There is a growing body of evidence revealing disproportionately higher rates of tobacco use among sexual and gender minority (SGM) individuals, compared to their heterosexual peers. These disparities have led organizations to support the inclusion of SGM in all local, state, and national tobacco prevention and control activities. In an attempt to leverage the online milieu for health-related interventions, mobile apps have been created to support tobacco cessation. However, evidence-based apps promoted by the National Cancer Institute are unpopular, remain poorly supported, and were not studied for use by SGM persons. Commercial apps, on the other hand, have been downloaded millions of times, contain many valuable features, and enjoy better infrastructure. Unfortunately, they are not evidence-based and have not been rigorously tested.

The University of Pittsburgh (Pitt) is currently conducting a randomized controlled trial to assess the feasibility and efficacy of using the Kwit tobacco cessation app with patients at UPMC Montefiore and Presbyterian hospitals (PI: Chu). It is a pragmatic clinical trial applying a patient-centered outcomes framework to ensure that-rather than focusing only on successful cessation-the study includes measurements for quality of life, mobility, and social interactions. We propose to extend the study to underrepresented SGM young adults.

Survey measures will be adapted as needed to address issues specific to the SGM population.

Enrollment

32 patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18-30
  • Self-identified as a sexual minority (gay, lesbian, bisexual)
  • Smokers interested in cessation (>1 cigarettes/day over the past 30 days)
  • Must own an Apple or Android based smartphone.

Exclusion criteria

  • Already receiving pharmacological and/or behavioral intervention or counseling for smoking cessation

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

32 participants in 1 patient group

Kwit smartphone app
Experimental group
Description:
This arm will receive the Kwit smartphone app.
Treatment:
Other: Kwit smartphone app

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems